Image

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Exploring Participant Preference for Screening Methods and Experience Into Colorectal Cancer Screening Programme

Recruiting
50-69 years
All
Phase N/A

Powered by AI

Overview

The goal of this low-risk interventional study is to analyze participants' assessment of colorectal cancer screening program through screening method preference and experience after FOBT analysis in screaned participant population for colorectal cancer; could include any of the following: both sexes, age 50-69 years, asympthomatic volunteers. The main aims to answer are:

  • Values of experience of participants into screening programme.
  • Values of preferences of participants for screening methods.

Participants will answer two questionnaires and they'll be given their information and clinical data to investigator or health personnel.

Eligibility

Inclusion Criteria:

  • Participants ages from 50 to 69 years (both included) at the time of informed consent signed.
  • Participants invited to participate in population-based screening programme who are eligible to undertake FOBT at the Primary Health Care Center.
  • Participants should sign an informed consent. They must understand the nature, significance, implications, and risks of the clinical study before signing the informed consent form.

Exclusion Criteria:

  • Participants who have not delivery a stool sample in the Primary Health Care Center before signing the informed consent form.
  • Participants with a previous colonoscopy in consequence of a FOBT positive result.
  • Participants who are in a dependent personal or non-medical relationship with the Sponsor or the Investigators.

Study details
    Screening for Colon Cancer
    Survey and Questionnaire

NCT06696534

ADVANCED MARKER DISCOVERY S.L.

13 May 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.